Antigenic modification of polypeptides

Details Antigenic modification of polypeptides Antigenic modification of polypeptides

A - Human Necessities

61

K

167/129

A61K 39/00 (2006.01)

Patent

CA 1223206

ANTIGENIC MODIFICATION OF POLYPEPTIDES Abstract of the Disclosure Vaccines are described comprising antigens as described in U. S. Patent No. 4,201,770 or Canadian Patent No. 1,057,742 or 1,085,383 in Arlacel/Squalene or Squalane vehicles, optionally with the addition of immuno-stimulating adjuvants. Antigens having similar activity may be produced by the linear polymerization of peptide fragments. Such vaccines may be used for contraception or treatment of hormone-related disease states and disorders, including hormone-associated car- cinomas.

415674

Affiliated with

Also associated with

Rating

Antigenic modification of polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antigenic modification of polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic modification of polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1273167